Baxion
Screening
Tags
Alerts
Theme
Lyell Immunopharma, Inc.
LYEL
·
NASDAQ
·
$16.37
Share Price as of 11/2
·
$382M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/06/26
10-Q
Q1 ended 03/31/26
05/06/26
10-K
FY 2025
03/12/26
10-Q
Q3 ended 09/30/25
11/12/25
10-Q
Q2 ended 06/30/25
08/12/25
Disclosures
Filter
8-K
Current report
09/10/26
8-K
Current report
08/06/26
8-K
Current report
06/15/26
8-K
Current report
05/06/26
8-K
Current report
03/12/26
Prospectuses and Registrations
Filter
S-3
Shelf registration
07/13/26
S-3
Shelf registration
04/03/26
S-8
Registration of securities for employees
03/12/26
424B5
Prospectus supplement
12/18/25
S-3
Shelf registration
12/05/25
Proxies
Filter
DEF 14A
Definitive proxy
04/24/26
DEFA14A
Additional proxy materials
04/24/26
DEF 14A
Definitive proxy
04/21/25
PRE 14A
Preliminary proxy
04/10/25
DEF 14A
Definitive proxy
04/22/24
Ownership
Filter
Form 4
Insider transaction
10/13/26
Form 3
Initial insider ownership
09/10/26
Form 4
Insider transaction
09/10/26
Form 4
Insider transaction
09/10/26
Form 4
Insider transaction
08/25/26
Other
Filter
EFFECT
Request for effectiveness
07/21/26
CORRESP
Correspondence with the SEC
07/17/26
UPLOAD
Letter from the SEC
07/16/26
ARS
Annual report to shareholders
04/24/26
EFFECT
Request for effectiveness
04/14/26
Latest Filings
Filter
8-K
Current report
09/10/26
10-Q
Q2 ended 06/30/26
08/06/26
8-K
Current report
08/06/26
EFFECT
Request for effectiveness
07/21/26
CORRESP
Correspondence with the SEC
07/17/26
Ownership
Filter
Form 4
Insider transaction
10/13/26
Form 3
Initial insider ownership
09/10/26
Form 4
Insider transaction
09/10/26
Form 4
Insider transaction
09/10/26
Form 4
Insider transaction
08/25/26